nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM3—nephrolithiasis	0.872	1	CbGaD
Glycopyrrolate—CHRM4—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00911	0.129	CbGpPWpGaD
Glycopyrrolate—CHRM5—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00872	0.123	CbGpPWpGaD
Glycopyrrolate—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00614	0.0867	CbGpPWpGaD
Glycopyrrolate—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00606	0.0856	CbGpPWpGaD
Glycopyrrolate—CHRM3—ureter—nephrolithiasis	0.00483	0.865	CbGeAlD
Glycopyrrolate—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00214	0.0506	CcSEcCtD
Glycopyrrolate—CHRM4—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00201	0.0284	CbGpPWpGaD
Glycopyrrolate—CHRM5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00193	0.0272	CbGpPWpGaD
Glycopyrrolate—CHRM4—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00169	0.0239	CbGpPWpGaD
Glycopyrrolate—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00164	0.0387	CcSEcCtD
Glycopyrrolate—CHRM5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00162	0.0229	CbGpPWpGaD
Glycopyrrolate—Oxyphenonium—CHRM3—nephrolithiasis	0.00146	0.158	CrCbGaD
Glycopyrrolate—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00136	0.0192	CbGpPWpGaD
Glycopyrrolate—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.00134	0.0317	CcSEcCtD
Glycopyrrolate—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00134	0.0189	CbGpPWpGaD
Glycopyrrolate—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0308	CcSEcCtD
Glycopyrrolate—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00125	0.0297	CcSEcCtD
Glycopyrrolate—Oxyphencyclimine—CHRM3—nephrolithiasis	0.00125	0.134	CrCbGaD
Glycopyrrolate—CHRM4—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00123	0.0174	CbGpPWpGaD
Glycopyrrolate—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00119	0.0281	CcSEcCtD
Glycopyrrolate—CHRM5—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00118	0.0167	CbGpPWpGaD
Glycopyrrolate—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00117	0.0277	CcSEcCtD
Glycopyrrolate—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00114	0.0161	CbGpPWpGaD
Glycopyrrolate—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00113	0.0159	CbGpPWpGaD
Glycopyrrolate—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00113	0.0266	CcSEcCtD
Glycopyrrolate—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00109	0.0258	CcSEcCtD
Glycopyrrolate—Procyclidine—CHRM3—nephrolithiasis	0.00106	0.114	CrCbGaD
Glycopyrrolate—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00103	0.0245	CcSEcCtD
Glycopyrrolate—Clidinium—CHRM3—nephrolithiasis	0.00102	0.109	CrCbGaD
Glycopyrrolate—Trospium—CHRM3—nephrolithiasis	0.000977	0.105	CrCbGaD
Glycopyrrolate—Trihexyphenidyl—CHRM3—nephrolithiasis	0.000969	0.104	CrCbGaD
Glycopyrrolate—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00096	0.0227	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.000954	0.0226	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.000946	0.0224	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000926	0.0219	CcSEcCtD
Glycopyrrolate—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000921	0.0218	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00089	0.0211	CcSEcCtD
Glycopyrrolate—Oxybutynin—CHRM3—nephrolithiasis	0.000887	0.0954	CrCbGaD
Glycopyrrolate—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000878	0.0208	CcSEcCtD
Glycopyrrolate—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.000864	0.0204	CcSEcCtD
Glycopyrrolate—Homatropine Methylbromide—CHRM3—nephrolithiasis	0.000863	0.0928	CrCbGaD
Glycopyrrolate—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000859	0.0203	CcSEcCtD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000857	0.0121	CbGpPWpGaD
Glycopyrrolate—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000832	0.0117	CbGpPWpGaD
Glycopyrrolate—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000829	0.0117	CbGpPWpGaD
Glycopyrrolate—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000824	0.0195	CcSEcCtD
Glycopyrrolate—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000821	0.0116	CbGpPWpGaD
Glycopyrrolate—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000818	0.0193	CcSEcCtD
Glycopyrrolate—Mepenzolate—CHRM3—nephrolithiasis	0.000816	0.0878	CrCbGaD
Glycopyrrolate—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000763	0.018	CcSEcCtD
Glycopyrrolate—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000716	0.0169	CcSEcCtD
Glycopyrrolate—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000705	0.0167	CcSEcCtD
Glycopyrrolate—Tension—Hydrochlorothiazide—nephrolithiasis	0.000702	0.0166	CcSEcCtD
Glycopyrrolate—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000701	0.0166	CcSEcCtD
Glycopyrrolate—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000695	0.0164	CcSEcCtD
Glycopyrrolate—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000674	0.016	CcSEcCtD
Glycopyrrolate—CHRM5—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000666	0.00939	CbGpPWpGaD
Glycopyrrolate—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000658	0.0156	CcSEcCtD
Glycopyrrolate—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000632	0.015	CcSEcCtD
Glycopyrrolate—CHRM4—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000603	0.0085	CbGpPWpGaD
Glycopyrrolate—CHRM4—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000603	0.0085	CbGpPWpGaD
Glycopyrrolate—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000596	0.0141	CcSEcCtD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000595	0.0084	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000595	0.0084	CbGpPWpGaD
Glycopyrrolate—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000589	0.0139	CcSEcCtD
Glycopyrrolate—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000584	0.0138	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000584	0.0138	CcSEcCtD
Glycopyrrolate—CHRM5—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000577	0.00814	CbGpPWpGaD
Glycopyrrolate—CHRM5—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000577	0.00814	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00057	0.00805	CbGpPWpGaD
Glycopyrrolate—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00057	0.0135	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000565	0.0134	CcSEcCtD
Glycopyrrolate—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000546	0.0129	CcSEcCtD
Glycopyrrolate—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000528	0.0125	CcSEcCtD
Glycopyrrolate—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000519	0.0123	CcSEcCtD
Glycopyrrolate—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000514	0.0122	CcSEcCtD
Glycopyrrolate—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000503	0.0119	CcSEcCtD
Glycopyrrolate—Pain—Hydrochlorothiazide—nephrolithiasis	0.000499	0.0118	CcSEcCtD
Glycopyrrolate—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000499	0.0118	CcSEcCtD
Glycopyrrolate—CHRM5—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000481	0.00679	CbGpPWpGaD
Glycopyrrolate—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000481	0.0114	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000478	0.0113	CcSEcCtD
Glycopyrrolate—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000469	0.00661	CbGpPWpGaD
Glycopyrrolate—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000467	0.00659	CbGpPWpGaD
Glycopyrrolate—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000464	0.011	CcSEcCtD
Glycopyrrolate—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000462	0.0109	CcSEcCtD
Glycopyrrolate—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000462	0.0109	CcSEcCtD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00043	0.00607	CbGpPWpGaD
Glycopyrrolate—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00043	0.0102	CcSEcCtD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000419	0.00592	CbGpPWpGaD
Glycopyrrolate—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000419	0.00991	CcSEcCtD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000418	0.0059	CbGpPWpGaD
Glycopyrrolate—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000413	0.00977	CcSEcCtD
Glycopyrrolate—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000406	0.00573	CbGpPWpGaD
Glycopyrrolate—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000406	0.00573	CbGpPWpGaD
Glycopyrrolate—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000401	0.00566	CbGpPWpGaD
Glycopyrrolate—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000401	0.00566	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000388	0.00548	CbGpPWpGaD
Glycopyrrolate—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000386	0.00913	CcSEcCtD
Glycopyrrolate—CHRM3—renal system—nephrolithiasis	0.000384	0.0688	CbGeAlD
Glycopyrrolate—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000372	0.00525	CbGpPWpGaD
Glycopyrrolate—CHRM3—kidney—nephrolithiasis	0.000372	0.0665	CbGeAlD
Glycopyrrolate—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000371	0.00878	CcSEcCtD
Glycopyrrolate—Rash—Hydrochlorothiazide—nephrolithiasis	0.000368	0.00871	CcSEcCtD
Glycopyrrolate—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000368	0.0087	CcSEcCtD
Glycopyrrolate—Headache—Hydrochlorothiazide—nephrolithiasis	0.000366	0.00865	CcSEcCtD
Glycopyrrolate—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000347	0.0082	CcSEcCtD
Glycopyrrolate—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000339	0.00478	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000333	0.0047	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000319	0.0045	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000303	0.00428	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—RGS14—nephrolithiasis	0.000293	0.00414	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.000281	0.00396	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—RGS14—nephrolithiasis	0.000266	0.00376	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000262	0.0037	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000259	0.00365	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.000255	0.0036	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—CHRM3—nephrolithiasis	0.000253	0.00358	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000243	0.00342	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—PTH—nephrolithiasis	0.000232	0.00327	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000224	0.00317	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.000222	0.00313	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000222	0.00313	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000198	0.0028	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000198	0.00279	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000197	0.00278	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000195	0.00275	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.00019	0.00268	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ADCY10—nephrolithiasis	0.000185	0.00261	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—DGKH—nephrolithiasis	0.00018	0.00254	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00018	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000179	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000177	0.0025	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.000177	0.0025	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000172	0.00243	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000171	0.00241	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000169	0.00238	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RGS14—nephrolithiasis	0.000157	0.00222	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000156	0.00221	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000156	0.0022	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000154	0.00218	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000151	0.00213	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000143	0.00202	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000137	0.00194	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000134	0.00189	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.000133	0.00188	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000132	0.00186	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	0.000131	0.00185	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	0.00013	0.00184	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GRHPR—nephrolithiasis	0.000126	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	0.000125	0.00177	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000125	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	0.000125	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	0.000124	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.000123	0.00174	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000121	0.00171	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	0.000121	0.00171	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.00012	0.00169	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	0.000119	0.00168	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	0.000114	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AGXT—nephrolithiasis	0.000113	0.00159	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	0.000106	0.0015	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000106	0.0015	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	0.000106	0.0015	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	0.000106	0.00149	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	0.000105	0.00148	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000102	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	0.000102	0.00144	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	9.66e-05	0.00136	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APRT—nephrolithiasis	9.58e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—SLC26A1—nephrolithiasis	9.58e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	9.53e-05	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	8.83e-05	0.00125	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	8.8e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	8.77e-05	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	8.72e-05	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	8.66e-05	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	8.02e-05	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	8e-05	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	7.92e-05	0.00112	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	7.68e-05	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	7.36e-05	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	7.17e-05	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.17e-05	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	7.14e-05	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.14e-05	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.07e-05	0.000998	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	7.07e-05	0.000998	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTH—nephrolithiasis	7.03e-05	0.000992	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—AQP1—nephrolithiasis	6.83e-05	0.000964	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTH—nephrolithiasis	6.73e-05	0.00095	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	5.18e-05	0.000731	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	5.11e-05	0.000722	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTH—nephrolithiasis	4.74e-05	0.000669	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTH—nephrolithiasis	4.72e-05	0.000667	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTH—nephrolithiasis	4.68e-05	0.00066	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	3.53e-05	0.000498	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	3.38e-05	0.000477	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	2.38e-05	0.000336	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	2.37e-05	0.000335	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	2.35e-05	0.000331	CbGpPWpGaD
